Actively Recruiting
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
Led by University of Pittsburgh · Updated on 2025-09-19
1750
Participants Needed
1
Research Sites
233 weeks
Total Duration
On this page
Sponsors
U
University of Pittsburgh
Lead Sponsor
N
National Cancer Institute (NCI)
Collaborating Sponsor
AI-Summary
What this Trial Is About
The trial will examine the effectiveness and facilitators and barriers of implementation of CARES, an integrated screening and stepped collaborative care intervention
CONDITIONS
Official Title
Hybrid Type I Effectiveness-implementation Cluster Randomized Controlled Trial of CARES
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Diagnosis of Cancer
- Age 18 years or older
- Read and write in English
You will not qualify if you...
- Evidence of thought disorder
- Evidence of delusions
- Evidence of hallucinations
- Evidence of suicidal ideation with a plan
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Pittsburgh Medical Center (UPMC) Cancer Center
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
Research Team
J
Jennifer L Steel, PhD
CONTACT
J
Jennifer L Steel
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here